Investment

Cradle Genomics
Cradle Genomics developed prenatal diagnostic tests that combined genomics with proprietary biochemistry.
Highlights
- The investment supported the shift toward safer, noninvasive prenatal testing.
- The company reflected Don’s interest in applying engineering rigor to medical diagnostics.
